![Antti Vuolanto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antti Vuolanto
Directeur Général chez
HERANTIS PHARMA OYJ
Profil
Antti Vuolanto is the founder of Targovax Oy, which was founded in 2009.
He held the title of Chief Operating Officer from 2014 to 2015.
Dr. Vuolanto is currently the Chief Executive Officer at Herantis Pharma Oyj since 2018.
In his former positions, he worked as a Principal at Mobidiag Oy and Medicel Oy.
He also served as the Executive Vice President at Circio Holding ASA from 2015 to 2017 and as the Chief Operating Officer at Valo Therapeutics Oy from 2017 to 2018.
Dr. Vuolanto obtained his doctorate degree from Aalto University School of Science & Technology in 2004.
Postes actifs de Antti Vuolanto
| Sociétés | Poste | Début |
|---|---|---|
| HERANTIS PHARMA OYJ | Directeur Général | 22/07/2022 |
Anciens postes connus de Antti Vuolanto
| Sociétés | Poste | Fin |
|---|---|---|
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Develops novel immunotherapies for cancer and infectious disease | Directeur des opérations | 01/02/2018 |
| CIRCIO HOLDING ASA | Corporate Officer/Principal | 01/02/2017 |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Focuses on the development and commercialization of targeted cancer immunotherapy | Fondateur | 01/07/2015 |
Mobidiag Oy
 Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Develops and markets molecular diagnostic solutions for gastrointestinal, antimicrobial resistance management and healthcare associated infections | Corporate Officer/Principal | - |
Medicel Oy
 Medicel Oy Information Technology ServicesTechnology Services Develops and provides software services for reverse engineering and modeling of biochemical pathways for drug discovery and validation | Corporate Officer/Principal | - |
Formation de Antti Vuolanto
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Mobidiag Oy
Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Develops and markets molecular diagnostic solutions for gastrointestinal, antimicrobial resistance management and healthcare associated infections | Commercial Services |
Medicel Oy
Medicel Oy Information Technology ServicesTechnology Services Develops and provides software services for reverse engineering and modeling of biochemical pathways for drug discovery and validation | Technology Services |
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Focuses on the development and commercialization of targeted cancer immunotherapy | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Herantis Pharma Oyj
 Herantis Pharma Oyj Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products to treat neurological disorders | Health Technology |
Valo Therapeutics Oy
Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Develops novel immunotherapies for cancer and infectious disease | Health Technology |
Aalto University School of Science & Technology
 Aalto University School of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
